LOWER RESPIRATORY TRACT DISEASE TREATMENT WITH CLARITHROMYCIN
Keywords:
macrolides, clarithromycin, community acquired pneumonia, atypical pneumonia
Abstract
Macrolides are frequently added to guidelines of pneumonia
treatment. They have antimicrobial activity against variety of pathogens that cause community acquired and atypical pneumonia. Macrolides also have immunomodulating properties. Clarithromycin is one of the newer macrolides, which has good penetration to pulmonary epithelial lining fluid. Its antimicrobial properties are increased by its 14-hydroxi metabolite.
How to Cite
1.
Dvareckaitė G. LOWER RESPIRATORY TRACT DISEASE TREATMENT WITH CLARITHROMYCIN [Internet]. PIA 2011 Sep.;9(2):40-43.[cited 2024 May 19 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/427
Section
Pharmacotherapy
